Douglas S Daniels
2PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Aug 23, 2024
BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.Ulrike Rauh, Guo Wei, Michael Serrano-Wu
|Aug 19, 2016
Point mutations at the catalytic site of PCSK9 inhibit folding, autoprocessing, and interaction with the LDL receptor.Colin W Garvie, Cara V Fraley, Nadine H Elowe
Pageof 1
